Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial von McIlroy, Graham, Gaskell, Charlotte, Jackson, Aimee, Yafai, Emily, Tasker, Rachel, Thomas, Catherine, Fox, Sonia, Boucher, Rebecca, Ghebretinsea, Fitsum, Harrison, Claire, Mead, Adam J, McMullin, Mary Frances

Volltext

Defective T‐cell response to COVID‐19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes von Loke, Justin, Upasani, Vinit, Gaskell, Charlotte, Fox, Sonia, Fletcher, Rachel, Thomas, Catherine, Hopkins, Louise, Kumari, Anita, Tang, Tina, Yafai, Emily, Boucher, Rebecca, Homer, Victoria, Toth, Arpad, Chan, Y. L. Tracey, Randall, Katie, Rider, Tom, O'Nions, Jenny, Drew, Victoria, Pillai, Arvind, Dungarwalla, Moez, Murray, Duncan, Khan, Anjum, Wandroo, Farooq, Moore, Sally, Krishnamurthy, Pramila, Huang, Ya‐Wen Jessica, Knapper, Steve, Byrne, Jenny, Zhao, Rui, Craddock, Charles, Parry, Helen, Moss, Paul, Stanworth, Simon J., Lowe, David M.

Volltext